As of Jun 28
| +0.79 / +2.59%|
The 7 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.50, with a high estimate of 94.00 and a low estimate of 39.00. The median estimate represents a +83.41% increase from the last price of 31.35.
The current consensus among 8 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.